Fimlab expands utilization of Aiforia’s clinical AI solutions
recent articles
Epredia and Aiforia Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program WINSTON-SALEM, N.C.--(BUSINESS WIRE)--PHC Group, a global healthcare company and leader in diagnostics and life sciences, will expand its...
South Korean biotech company GC Cell Corp. said Thursday that it signed a joint research and supply agreement with medical artificial intelligence (AI) company Lunit Inc. for new drug candidate AB-201. Under the agreement, GC Cell will conduct...
Owkin to collaborate with MSD to develop and commercialize AI-powered digital pathology Microsatellite Instability High (MSI-H) diagnostics for four types of cancer. The aim is to pre-screen patients for the MSI-H biomarker, which is found...
Driving Quality and Efficiency in Digital Pathology Workflows with AI-Enabled Tumor Assessment Boston, MA – December 14, 2023 – PathAI, a global leader in AI-powered pathology, today announced TumorDetect on AISightTM, PathAI’s...
Concord, MA (12/14/2023) – Corista, a leader in digital pathology solutions, announced its DP3 platform has been certified with the CE In Vitro Diagnostic (IVDR) marking, for routine diagnosis in the European Union and United Kingdom. The CE...
As I mentioned about 6 months ago, our practice has adopted the use of digital pathology. While it is "digital", it is simply, pathology. At least 80% of my caseload is now viewed on a monitor. The work is done with mouse rather than...
